Skip to content

Effect of active vs passive posterolateral MWM in subjects with adhesive capsulitis: a randomized controlled trial

Effect of active vs passive posterolateral MWM in subjects with adhesive capsulitis: a randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103530
Enrollment
51
Registered
2026-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M70-M79- Other soft tissue disorders

Interventions

Intervention1: Conventional treatment + Active Posterolateral MWM: Active MWM (Mobilization With Movement) with Posterolateral GlideTechnique The patient is positioned in sitting with the arm relaxed
any discomfort halts the set. Control Intervention1: Conventional treatment: Hot moist pack: A moist hot pack is applied over the anterolateral shoulder for 15 minutes. Codman s pendular exercise: Th

Sponsors

Irfan Khan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both genders, age 40-60 years old. Clinical diagnosis of adhesive capsulitis, stage 2 or 3, based on history and physical examination. Symptom duration is 1 month to 12 months Pain more than 3 on 10 on NPRS during movement. Patient willing to participate.

Exclusion criteria

Exclusion criteria: Any fracture of the proximal humerus, clavicle, scapula, or AC joint reconstruction, or any shoulder surgery within the previous 12 months. Stage 2 or 3 full-thickness rotator cuff tear requiring surgical repair or clinically suspected large tear (positive drop arm, weakness). Active inflammatory arthropathy (rheumatoid arthritis) or septic arthritis of the shoulder. Neurological disorder affecting shoulder function e.g. cervical radiculopathy, brachial plexopathy, post stroke shoulder involvement Corticosteroid injection in shoulder within past 4 weeks. Uncontrolled diabetes (with severe neuropathy), malignancy, severe osteoporosis, or contraindication to manual therapy. History of CABG or open-heart surgery in the past 6 months.

Design outcomes

Primary

MeasureTime frame
1.Shoulder Pain and Disability Index (SPADI) Shoulder function and disability will be assessed using the Shoulder Pain and Disability Index (SPADI). SPADI is a validated, self-reported outcome measure consisting of pain and disability subscales used to evaluate the functional status of the shoulder 2.Range of Motion (ROM) using Goniometer Active range of motion of the shoulder joint will be assessed using a standard universal goniometer. The movements evaluated will include shoulder flexion, abduction, internal rotation, and external rotation. Goniometric measurements will be taken during pre-assessment and post-assessment sessions.Timepoint: at the baseline and at the end of 2 weeks

Secondary

MeasureTime frame
Numerical Pain Rating Scale (NPRS) Pain intensity will be assessed using the Numerical Pain Rating Scale (NPRS). NPRS is a subjective scale ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Pain scores will be documented during pre-assessment and post-assessment periods.Timepoint: at the baseline and at the end of 2 weeks

Countries

India

Contacts

Public ContactIrfan Khan

KLE INSTITUTE OF PHYSIOTHERAPY

santoshmetgud@klekipt.edu.in9880088400

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026